Ignite Creation Date:
2024-05-06 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 1:53 PM
Study NCT ID:
NCT04697446
Status:
UNKNOWN
Last Update Posted:
2021-08-10
First Post:
2020-12-16
Brief Title:
External Control Observational Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC
Sponsor:
Blueprint Medicines Corporation
Organization:
Blueprint Medicines Corporation
Organization Data
Organization:
Blueprint Medicines Corporation
Class:
INDUSTRY
Study ID:
BLU-667-2404
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Blueprint Medicines Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Analysis Group Inc | INDUSTRY |